📣 VC round data is live. Check it out!
- Public Comps
- Phreesia
Phreesia Valuation Multiples
Discover revenue and EBITDA valuation multiples for Phreesia and similar public comparables like Heren Health, Echo IQ, GPI Group, Veradigm and more.
Phreesia Overview
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Founded
2005
HQ

Employees
2.1K
Website
Financials (LTM)
EV
$562M
Valuation Multiples
Start free trialPhreesia Financials
Phreesia reported last 12-month revenue of $491M and EBITDA of $109M.
In the same LTM period, Phreesia generated $403M in gross profit, $109M in EBITDA, and $6M in net income.
Revenue (LTM)
Phreesia P&L
In the most recent fiscal year, Phreesia reported revenue of $481M and EBITDA of $102M.
Phreesia is profitable as of last fiscal year, with gross margin of 68%, EBITDA margin of 21%, and net margin of 0%.
Financial data powered by Morningstar, Inc.
Phreesia Stock Performance
Phreesia has current market cap of $533M, and enterprise value of $562M.
Market Cap Evolution
Phreesia's stock price is $8.77.
Phreesia share price decreased by 4.8% in the last 30 days, and by 64.2% in the last year.
Phreesia has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $562M | $533M | -4.6% | -4.8% | -28.9% | -64.2% | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPhreesia Valuation Multiples
Phreesia trades at 1.1x EV/Revenue multiple, and 5.1x EV/EBITDA.
EV / Revenue (LTM)
Phreesia Financial Valuation Multiples
As of May 15, 2026, Phreesia has market cap of $533M and EV of $562M.
Phreesia has a P/E ratio of 86.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Phreesia Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Phreesia Margins & Growth Rates
Phreesia grew revenue by 7% and EBITDA by 27% in the last fiscal year.
In the most recent fiscal year, Phreesia reported gross margin of 68%, EBITDA margin of 21%, and net margin of 0%.
Phreesia Margins
Phreesia Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Phreesia Operational KPIs
Phreesia's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Phreesia's Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Phreesia's Rule of X is 43% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Phreesia Competitors
Phreesia competitors include Heren Health, Echo IQ, GPI Group, Veradigm, Artrya, Goodwill E-Health Info, Guiyang Longmaster, Beijing Sunwayworld, Medley Inc. and Equasens.
Most Phreesia public comparables operate across Healthcare Software, EHR & Practice Management, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 7.3x | — | 39.1x | — | |||
| 7383.8x | 772.5x | (127.7x) | (127.4x) | |||
| 1.4x | 1.4x | 6.8x | 6.6x | |||
| — | 0.5x | — | 3.4x | |||
| 26000.0x | 189.8x | (54.8x) | (38.3x) | |||
| 8.5x | 7.9x | (14.9x) | (20.6x) | |||
| 12.6x | — | 100.2x | — | |||
| 7.4x | — | 127.7x | — | |||
This data is available for Pro users. Sign up to see all Phreesia competitors and their valuation data. Start Free Trial | ||||||
Phreesia Funding History
Before going public, Phreesia raised $47M in total equity funding, across 2 rounds.
Phreesia Funding Rounds
Phreesia M&A Activity
Phreesia has acquired 5 companies to date.
Last acquisition by Phreesia was on September 4th 2025. Phreesia acquired AccessOne for $160M (EV/Revenue multiple of ).
Latest Acquisitions by Phreesia
| Description | AccessOne is a healthcare fintech firm delivering patient financing and payment platforms. It integrates with electronic health records like Epic and Cerner for automated billing, installment plans, and self-service portals. Chicago-based AccessOne processes payments through ACH, credit cards, and text reminders, supporting hospitals and providers with real-time eligibility checks and analytics dashboards. | Access eForms is a forms automation solution for healthcare organizations streamlining paperless processes. Louisville-based since 2003, it deploys across hospitals and IDNs with integrations to EHRs like Epic and Cerner. Serving hundreds of facilities worldwide, the platform enables mobile access for admissions, HR, and finance forms, ensuring HIPAA compliance. Access eForms supports over 1,000 form templates, reducing printing by 90% in deployed sites. | MediFind is a healthcare technology platform based in New York City. It leverages AI to identify global medical experts from 2.5 million physicians across datasets for conditions ranging from rare diseases to cancer. Founded from technology used by Roche for 18 years, MediFind delivers expert finder, second opinions, clinical trial matching, and research summaries from 100,000 monthly publications. The platform serves patients, pharma firms, and hospitals in the United States and Europe. | Insignia Health is a Portland, Oregon-based company providing the Patient Activation Measure assessment tool. The platform quantifies patient engagement levels to guide interventions in healthcare delivery. Adopted by providers like Kaiser Permanente and Humana, it integrates with EHR systems to personalize care plans and reduce costs. | |
| HQ Country | |||||
| HQ City | Charlotte, SC | Belo Horizonte | Philadelphia, PA | Portland, OR | |
| Deal Date | 4 Sep 2025 | 14 Aug 2023 | 14 Jul 2023 | 13 Dec 2021 | |
| Valuation | $160M | $38M | $9M | $34M | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Phreesia acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Phreesia
| When was Phreesia founded? | Phreesia was founded in 2005. |
| Where is Phreesia headquartered? | Phreesia is headquartered in United States. |
| How many employees does Phreesia have? | As of today, Phreesia has over 2K employees. |
| Who is the CEO of Phreesia? | Phreesia's CEO is Chaim Indig. |
| Is Phreesia publicly listed? | Yes, Phreesia is a public company listed on NYSE. |
| What is the stock symbol of Phreesia? | Phreesia trades under PHR ticker. |
| When did Phreesia go public? | Phreesia went public in 2019. |
| Who are competitors of Phreesia? | Phreesia main competitors include Heren Health, Echo IQ, GPI Group, Veradigm, Artrya, Goodwill E-Health Info, Guiyang Longmaster, Beijing Sunwayworld, Medley Inc., Equasens. |
| What is the current market cap of Phreesia? | Phreesia's current market cap is $533M. |
| What is the current revenue of Phreesia? | Phreesia's last 12 months revenue is $491M. |
| What is the current revenue growth of Phreesia? | Phreesia revenue growth (NTM/LTM) is 7%. |
| What is the current EV/Revenue multiple of Phreesia? | Current revenue multiple of Phreesia is 1.1x. |
| Is Phreesia profitable? | Yes, Phreesia is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Phreesia? | Phreesia's last 12 months EBITDA is $109M. |
| What is Phreesia's EBITDA margin? | Phreesia's last 12 months EBITDA margin is 22%. |
| What is the current EV/EBITDA multiple of Phreesia? | Current EBITDA multiple of Phreesia is 5.1x. |
| What is the current FCF of Phreesia? | Phreesia's last 12 months FCF is $64M. |
| What is Phreesia's FCF margin? | Phreesia's last 12 months FCF margin is 13%. |
| What is the current EV/FCF multiple of Phreesia? | Current FCF multiple of Phreesia is 8.8x. |
| How many companies Phreesia has acquired to date? | As of May 2026, Phreesia has acquired 5 companies. |
| What was the largest acquisition by Phreesia? | $160M acquisition of AccessOne on 4th September 2025 was the largest M&A Phreesia has done to date. |
| What companies Phreesia acquired? | Phreesia acquired AccessOne, Access eforms, Insignia Health, MediFind, and Vital Score Health (now Phreesia). |
| In how many companies Phreesia has invested to date? | Phreesia hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Phreesia
Lists including Phreesia
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

